Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Nefrología (English Edition) - Volume 36, Issue 1, January–February 2016, Pages 72-75

Emanuel Ferreira, Nuno Oliveira, Maria Marques, Luís Francisco, Ana Santos, Armando Carreira, Mário Campos,